Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
First-in-human PK similarity study of DRL_AB versus EU and US Orencia in healthy male volunteers
NL-OMON51534Phase 1Completed
- Sponsor
- Dr. Reddy's Laboratories
- Start
- Jun 2022
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of DRL_AB and abatacept in rheumatoid arthritis (RA) (3 arms), sponsored by Dr. Reddy's Laboratories. Primary endpoint: Pharmacokinetic similarity. Started Jun 2022; status: completed.
02
Drugs
DRL_ABabatacept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NL-OMON51534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON51534.